Evidence map›Paper›PMID 32244978›Full record

ArticleInternational journal of molecular sciences2020

Sexually Dimorphic Behavioral Profile in a Transgenic Model Enabling Targeted Recombination in Active Neurons in Response to Ketamine and (2R,6R)-Hydroxynorketamine Administration.

David P Herzog, Ratnadevi M Mellema, Floortje Remmers, Beat Lutz, Marianne B Müller, Giulia Treccani

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 2 countries.

David P HerzogLaboratory of Translational Psychiatry and Focus Program Translational Neurosciences, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.ORCID 0000-0001-6406-7990
Ratnadevi M MellemaLaboratory of Translational Psychiatry and Focus Program Translational Neurosciences, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.
Floortje RemmersInstitute of Physiological Chemistry, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.ORCID 0000-0002-8436-0606
Beat LutzInstitute of Physiological Chemistry, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.
Marianne B MüllerLaboratory of Translational Psychiatry and Focus Program Translational Neurosciences, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.
Giulia TreccaniLaboratory of Translational Psychiatry and Focus Program Translational Neurosciences, Johannes Gutenberg University Medical Center Mainz, 55128 Mainz, Germany.
Johannes Gutenberg University Mainz · DE

Funding

Boehringer Ingelheim Stiftung BIS09Deutsche Forschungsgemeinschaft CRC1193NARSAD Brain and Behaviour Foundation, USA 22752Sundhed og Sygdom, Det Frie Forskningsråd 5053-00103A
6 · The paper itself

Abstract

backgroundRapid-acting antidepressants ketamine and (2R,6R)-hydroxynorketamine ((2R,6R)-HNK) have overcome some of the major limitations of classical antidepressants. However, little is known about sex-specific differences in the behavioral and molecular effects of ketamine and (2R,6R)-HNK in rodents.

methodsWe treated mice with an intraperitoneal injection of either saline, ketamine (30 mg kg

resultsArc-CreERT2 × CAG-Sun1/sfGFP mice showed sex differences in sociability and anxiety tests. Moreover, ketamine and (2R,6R)-HNK had opposite effects in the forced swim test (FST) depending on gender. In addition, in male mice, ketamine-treated animals were less immobile compared to (2R,6R)-HNK, thus showing a different profile of the two drugs in the FST. At the molecular level we identified

conclusionArc-CreERT2 × CAG-Sun1/sfGFP mice showed sex differences in social and anxiety behavior and a different pattern between ketamine and (2R,6R)-HNK in the FST in male and female mice. At the molecular level, female mice treated with ketamine showed an increase of

Indexed as

Behavior, AnimalRecombination, GeneticSex CharacteristicsAnimalsAnxietyBrain-Derived Neurotrophic FactorCell NucleusDisease Models, AnimalFemaleGreen Fluorescent ProteinsHippocampusKetamineMaleMemory, EpisodicMice, TransgenicNeurons6-hydroxynorketamineBrain-Derived Neurotrophic FactorGreen Fluorescent ProteinsKetamineactivated neuronsantidepressantBDNFbehaviorhydroxynorketamineketaminerapid-actingsex difference

Identifiers

PMID32244978
PMCPMC7139539
OpenAlexW3012444739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.